- Main
Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy
- Tan, Chia Jie;
- Lim, Sheree Wan Ting;
- Toh, Yi Long;
- Ng, Terence;
- Yeo, Angie;
- Shwe, Maung;
- Foo, Koon Mian;
- Chu, Pat;
- Jain, Amit;
- Koo, Si-Lin;
- Dent, Rebecca A;
- Ng, Raymond Chee Hui;
- Yap, Yoon Sim;
- Lim, Elaine H;
- Loh, Kiley Wei-Jen;
- Chay, Wen Yee;
- Lee, Guek Eng;
- Tan, Tira Jing Ying;
- Beh, Sok Yuen;
- Wong, Mabel;
- Chan, Jack Junjie;
- Khor, Chiea Chuen;
- Ho, Han Kiat;
- Chan, Alexandre
- et al.
Published Web Location
https://doi.org/10.1007/s12035-018-1410-4Abstract
Cancer-related cognitive impairment (CRCI) adversely affects cancer patients. We had previously demonstrated that the BDNF Val66Met genetic polymorphism is associated with lower odds of subjective CRCI in the multitasking and verbal ability domains among breast cancer patients receiving chemotherapy. To further assess our previous findings, we evaluated the association of BDNF Val66Met polymorphism with subjective and objective CRCI in a temporally separate cohort of patients and pooled findings from both the original (n = 145) and current (n = 193) cohorts in a meta-analysis. Subjective CRCI was assessed using FACT-Cog. Objective CRCI was evaluated using computerized neuropsychological tests. Genotyping was carried out using Sanger sequencing. The association of BDNF Val66Met genotypes and CRCI was examined with logistic regression. A fixed-effect meta-analysis was conducted using the inverse variance method. In the meta-analysis (n = 338), significantly lower odds of CRCI were associated with Met allele carriers based on the global FACT-Cog score (OR = 0.52, 95% CI 0.29-0.94). Furthermore, Met allele carriers were at lower odds of developing impairment in the domains of memory (OR = 0.34, 95% CI: 0.17-0.70), multitasking (OR = 0.33, 95% CI: 0.18-0.59), and verbal ability (OR = 0.46, 95% CI: 0.24-0.88). Consistent with the previous study, lower odds of subjective CRCI among patients with the BDNF Met allele was observed after adjusting for potential confounders in the multitasking (OR = 0.30, 95% CI: 0.14-0.67) domain. In conclusion, carriers of the BDNF Met allele were protected against global subjective CRCI, particularly in the domains of memory, multitasking, and verbal ability. Our findings further contribute to the understanding of CRCI pathophysiology.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-